Treatment of asthma in patients adequately and not adequately controlled with inhaled corticosteroids, short- and long-acting β2-acting agonist. Symptomatic treatment of patients with severe COPD (FEV1 <50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
